Surgical adhesion barriers are implants or solutions used to prevent internal scarring due to sticking of tissues or internal organs to each other after surgery or during healing process. Majority of adhesion barrier products are in nascent stage of product life cycle and thus market is evolving gradually. Adhesion barrier products considered in the report include film-based, solution-based, and gel-based adhesion barriers.

The global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers

High number of cardiovascular procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart transplants were performed in the U.S. in 2014 and 2017, respectively.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Opportunities

R&D of absorbable hemostats is expected to offer lucrative growth opportunities for players in the market. For instance, in October 2019, researchers from Institute of Pharmacology and Toxicology, Technische Universität Dresden, Germany, reported that naturally prefabricated marine biomaterials can aid in development of new sponge chitin-based absorbable hemostats as alternatives to cellulose-based fabrics.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Restraints

Restricted use of synthetic tissue sealants is expected to hinder growth of the market. Significant restrictions and complications are associated with the use of synthetic polymer-based tissue glues in the internal applications. For instance, cyanoacrylate glues have adequate acceptability for most orthopedic surgical procedures, however, are not yet cleared for use in the internal tissue applications because of toxic effects. They additionally need sufficient adaptability for use in numerous procedures.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3721

Key Takeaways:

Hemostat held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 41.1% share in terms of value, followed by Internal Tissue Sealants, and adhesion barriers respectively. Rising volumes of surgical procedures performed across the world coupled with increasing number of trauma and accident injury cases is expected to foster growth of hemostats segment. For instance, according to the Health and Social Care Information Centre (HSCIC), surgery is one of the most important treatments offered by NHS care in the U.K., and accounted for 4.7 million admissions across multiple medical domains in 2013 -14.

Orthopedic Surgeries segment held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 27.5% share in terms of value, followed by Cardiovascular Surgeries and Neurological Surgeries, respectively. Highest prevalence of bone related disorders has been reported in North America. For instance, according to the statistics by WHO, in U.S., by the year 2040, around 78.4 million adults aged 18 years and older will have doctor-diagnosed arthritis, compared to 54.4 million adults in 2013-2015

Hospitals segment held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 67.1% share in terms of value, followed by ASCs and specialty clinics, respectively

Market Trends

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in June 2019, Ethicon, part of the Johnson & Johnson Medical Devices Companies, received a 510(k) clearance from the FDA for its Vistaseal applicators, which spray a biological sealant to stem moderate bleeding during open or laparoscopic surgical procedures.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/surgical-hemostats-internal-tissue-sealants-and-adhesion-barriers-market-3721

Major players in the market are also focussed on adopting M&A strategies to expand their product portfolio. For instance, in March 2018, Baxter International Inc. completed acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Competitive Landscape

Major players operating in the global surgical hemostats, internal tissue sealants and adhesion barriers market include, Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring.

Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Key Developments

December 2019: Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched VISTASEAL Fibrin Sealant (Human) to help surgeons manage bleeding during surgery

December 2018: Baxter International Inc. launched its disposable curved applicator that is designed to enhance the delivery of its Floseal Hemostatic Matrix product line

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3721

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737